Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce3ceb49a54edfbc6b35e9109347c463 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate |
1994-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_846bd3dbbaa2a03db54dfc5d95c9b334 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1757603e50b53f2709723bb7c0dad420 |
publicationDate |
1995-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H07309777-A |
titleOfInvention |
Preventive and therapeutic agent for bone fracture |
abstract |
(57) [Summary] [Structure] A prophylactic and therapeutic agent for bone fracture, which comprises ribonuclease BL 4 , ribonuclease PL 3 or ribonuclease HT-29 as an active ingredient. [Effect] Since the present agent promotes the differentiation of osteoblasts, it is effective in the prevention and treatment of diseases such as fractures that require the promotion of bone differentiation and proliferation. |
priorityDate |
1994-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |